LloydsPharmacy

Yooma Wellness Provides Vitality CBD Novel Foods Update

Retrieved on:

Friday, April 1, 2022

Company, Tesco, Work, ASDA, Oil, Sale, Marketing, Novel food, Skin care, Compliance, Commercial, CEO, YOOM, EBay, FSA, Boot, CBD, LloydsPharmacy, GLOBE, News, CSE, Amazon, Vitality

Toronto, Ontario, Canada, April 01, 2022 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma") (CSE: YOOM, AQSE: YOOM), a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands, is pleased to announce that the Company's wholly owned subsidiary, Vitality CBD and its extensive product range have successfully been published on the UK Food Standard Agencies (FSA) Novel Foods approved list for CBD.

Key Points:

Toronto, Ontario, Canada, April 01, 2022 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma") (CSE: YOOM, AQSE: YOOM), a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands, is pleased to announce that the Company's wholly owned subsidiary, Vitality CBD and its extensive product range have successfully been published on the UK Food Standard Agencies (FSA) Novel Foods approved list for CBD.
Those not included on the FSAs CBD Novel Food register will subsequently have to be taken off sale in the UK.
Phillip Glyn, Commercial Director of Vitality, said: After 18 months of work and investment, Vitality CBD is delighted and proud to be included on the Novel Food Public List.
Vitality CBD is the most widely stocked brand of CBD in the UK with products distributed in national retailers such as Boots, Tesco, ASDA and Lloyds Pharmacy.

Yooma Wellness Announces Vitality CBD, Blossom and MYO Plant Nutrition Available on eBay

Retrieved on:

Tuesday, February 22, 2022

ASDA, GLOBE, Commercial, CSE, EBay, FSA, CBD, Tesco, LloydsPharmacy, Globe, Selfridges, Oil, Company, Sale, Immunity, Mental health, US, Vitality, Skin care, Ocado Group, Croydon, Marketing, Stock, CAGR, Holland & Barrett, Solution, CEO, YOOM, Online shopping, Dietary supplement, Blossom, Boot (disambiguation), Amazon

Toronto, Ontario, Canada, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma") (CSE: YOOM, AQSE: YOOM), a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands, is pleased to announce eBay has added Vitality CBD, Blossom Skincare ("Blossom") and MYO Plant Nutrition ("MYO") to its CBD pilot programme, marking a significant step forward for the global wellness market.

Key Points:

Toronto, Ontario, Canada, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma") (CSE: YOOM, AQSE: YOOM), a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands, is pleased to announce eBay has added Vitality CBD, Blossom Skincare ("Blossom") and MYO Plant Nutrition ("MYO") to its CBD pilot programme, marking a significant step forward for the global wellness market.
Fifty-one Vitality CBD SKUs, five CBD oils from Blossom and four MYO CBD SKUs will be available for purchase.
We are delighted that Vitality CBD, Blossom and MYO have been invited to join its CBD pilot programme.
MYO Plant Nutrition is a UK-based plant nutrition business with a mission to help people improve their full-body wellness.

LloydsPharmacy chooses MRI Software's Horizon CRE for lease management and accounting

Retrieved on:

Tuesday, January 18, 2022

Aviation, Accounting, IFRS 16, International, Documentation, IFRS, International Financial Reporting Standards, Senior, Freedom, Solution, Software, LloydsPharmacy, Efficiency, Work, MRI, Property technology, MRI Software, Organization, Property management

LONDON, Jan. 18, 2022 /PRNewswire/ -- MRI Software, a global leader in real estate solutions, announces that LloydsPharmacy, a leading UK high street brand, has selected MRI Horizon CRE to manage its lease portfolio and financial compliance, including International Financial Reporting Standard (IFRS 16). In working with MRI, LloydsPharmacy will deploy Horizon CRE, a cloud-based lease management and accounting platform, to more easily handle their real estate challenges and complexities of IFRS 16. The accounting standard came into effect on 1 January 2019 and requires that all leases be recorded on balance sheets to increase the transparency of business exposure to costs.

Key Points:

In working with MRI, LloydsPharmacy will deploy Horizon CRE, a cloud-based lease management and accounting platform, to more easily handle their real estate challenges and complexities of IFRS 16.
"We needed a purpose-built solution to handle the intricacies and nuances of our lease portfolio and automate elements of lease management that would otherwise require manual input.
The team at LloydsPharmacy recognises their responsibility to continue to meet today's IFRS 16 lease accounting standards, and we're excited to integrate Horizon CRE into their operations.
LloydsPharmacy will be able to proactively manage its lease management requirements and related matters with a tool that allows for effective, clear and accurate information to be communicated to regulators, management, investors and other stakeholders."

Yooma Wellness Announces Launch of MYO Plant Nutrition in Boots Stores Across the UK

Retrieved on:

Monday, January 17, 2022

CAGR, BCAA, US, CBD, CEO, GLOBE, Health, Holland & Barrett, Marketing, Immunity, EAA, CSE, Sale, LloydsPharmacy, Brain, YOOM, Partnership, Dietary supplement, Amazon, Boot (disambiguation), Selfridges

The listing includes MYOs Plant Proteins in 838 stores, branched-chain amino acids (BCAA) and essential amino acids (EAA) in up to 574 stores, and functional sprays in 522 stores.

Key Points:

The listing includes MYOs Plant Proteins in 838 stores, branched-chain amino acids (BCAA) and essential amino acids (EAA) in up to 574 stores, and functional sprays in 522 stores.
MYO products are 100%-plant-based, use clean and innovative ingredients, and focus on the growing area of full-body plant-based wellness, which includes nutrition, the gut, brain, immunity and other key elements of wellness.
James Lawson Baker, Founder of MYO Plant Nutrition, commented: This is a major milestone for MYO and we are absolutely delighted to be partnering with Boots, the leading health and beauty retailer in the UK.
Jordan Greenberg, CEO of Yooma, said: MYO Plant Nutrition is an exceptional example of how Yoomas buy-and-build strategy creates shareholder value.

MedAvail Announces Changes to Executive Management and Board of Directors; Preliminary Fourth Quarter and FY 2021 Results

Retrieved on:

Tuesday, January 11, 2022

Health, Technology, Other Technology, Software, General Health, Pharmaceutical, Giant, Online, Forward-looking statement, Patient, Technology, Giant Eagle, Medco Health Solutions, 23andMe, University, Private Securities Litigation Reform Act, SEC, Ohio Northern University, General manager, Change Healthcare, FirstBank Holding Co, Risk, NASDAQ, Brown University, Growth, CEO, University of Worcester, Solution, American Medical Association, Zooplus, Leadership, Review, Â, U.S. Securities and Exchange Commission, Acquisition, Nasdaq, Health, Medicare, Blackstone, Pharmacist, Consumer, Sale, LloydsPharmacy, Business, Improper integral, Mission statement, Security (finance), Head, Senior, Technology Business Management Council, Annual report, Management, Hospital, Pharmaceutical industry, Science, Allscripts, Pharmacy, Mark Doerr, Laurie McGraw, Paul Johnson, MedAvail, SpotRx, MARK DOERR, LAURIE MCGRAW, PAUL JOHNSON, MEDAVAIL, SPOTRX

The company also announced changes to its board of directors and reported preliminary fourth quarter and full year 2021 revenue results.

Key Points:

The company also announced changes to its board of directors and reported preliminary fourth quarter and full year 2021 revenue results.
On the appointment of Mr. Doerr, Mr. Faulkner continued, The Board and I are very pleased that Mark will be leading MedAvail forward.
MedAvail intends to report its full year and fourth quarter 2021 financial results in February 2022.
If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements.

Yooma Wellness Announces UK Rollout of Vitality CBD Products in ASDA Stores

Retrieved on:

Monday, November 22, 2021

Well, Pharmacy, Sale, CEO, Health care, YOOM, Tesco, Health, CBD, CSE, Oil, GLOBE, Boot, Marketing, Commercial, RRP, LloydsPharmacy, The Independent, Pharmacist, Skin care, Vitality, Dietary supplement

TORONTO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma") (CSE: YOOM, AQSE: YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today announced that ASDA, one of Britains leading retailers, is now stocking 17 of Vitality CBD Limiteds ("Vitality CBD") well-being and active CBD products in ASDAs vitamin aisles and in-store pharmacies, making Vitality CBD the most extensive CBD product range in ASDA.

Key Points:

TORONTO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma") (CSE: YOOM, AQSE: YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today announced that ASDA, one of Britains leading retailers, is now stocking 17 of Vitality CBD Limiteds ("Vitality CBD") well-being and active CBD products in ASDAs vitamin aisles and in-store pharmacies, making Vitality CBD the most extensive CBD product range in ASDA.
Phillip Glyn, Commercial Director of Vitality CBD, said: We are delighted to be a chosen CBD supply partner of ASDA.
The UK rollout on this wide range of products will provide Vitality with a platform to generate additional revenues across the 300 ASDA stores in the UK.
Vitality CBD is the most widely stocked brand of CBD in the UK with products distributed in national retailers such as Boots, Tesco, ASDA and Lloyds Pharmacy.

DGAP-News: In its biggest deal in history, AURELIUS acquires McKesson UK

Retrieved on:

Monday, November 1, 2021

In its biggest deal in history, AURELIUS acquires McKesson UK

Key Points:

In its biggest deal in history, AURELIUS acquires McKesson UK
The issuer is solely responsible for the content of this announcement.
In its biggest deal in history, AURELIUS acquires McKesson UK
- AURELIUS agrees to acquire McKesson UK, the UK's leading fully integrated healthcare provider, across retail, wholesale, homecare and digital platforms for an enterprise value of GBP 477m
- Co-investment structure together with AURELIUS Equity Opportunities SE & Co. KGaA is already paying off
Munich/London, November 1, 2021 - In its largest deal to date, AURELIUS today announces the acquisition of McKesson UK in a corporate carve-out from US healthcare company McKesson Corporation, Irving, Texas.
Our agreement with McKesson builds on AURELIUS' proven track record as a trusted investor in corporate carve-outs, leveraging AURELIUS' operational expertise to grow portfolio companies.
With its group charity AURELIUS Refugee Initiative e.V., AURELIUS provides comprehensive support for refugees on their way towards a better life.

McKesson Corporation Enters Agreement to Sell UK Businesses to AURELIUS

Retrieved on:

Monday, November 1, 2021

McKesson Corporation (NYSE: MCK) today announced that it has entered into an agreement to sell its UK businesses to AURELIUS, a pan-European asset management group with offices in Munich, London, Stockholm, Madrid, Amsterdam, Milan and Luxembourg.

Key Points:

McKesson Corporation (NYSE: MCK) today announced that it has entered into an agreement to sell its UK businesses to AURELIUS, a pan-European asset management group with offices in Munich, London, Stockholm, Madrid, Amsterdam, Milan and Luxembourg.
The transaction includes the sale of McKesson UK businesses LloydsPharmacy, LloydsDirect (previously Echo by LloydsPharmacy), AAH Pharmaceuticals, LloydsPharmacy Clinical Homecare, LloydsPharmacy Online Doctor, MASTA and John Bell & Croyden.
AURELIUS expects to support McKesson UK by further investing in and growing each of its business divisions.
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions.

VIRALEZE™ antiviral nasal spray launched in ADMENTA Italia Group pharmacies in Italy

Retrieved on:

Friday, October 8, 2021

McKesson Corporation, Pharmacy, McKesson Europe, Marketing, Virus, LloydsPharmacy, Hospital, Severe acute respiratory syndrome coronavirus 2, CEO, Nose, Grocery store

MELBOURNE, Australia, Oct. 8, 2021 /PRNewswire/ --Australian biotech company Starpharma today announced it has signed a sales and distribution agreement for its VIRALEZE antiviral nasal spray with ADMENTA Italia Group (ADMENTA), a leading pharmaceutical retail and wholesale distribution company in Italy.

Key Points:

MELBOURNE, Australia, Oct. 8, 2021 /PRNewswire/ --Australian biotech company Starpharma today announced it has signed a sales and distribution agreement for its VIRALEZE antiviral nasal spray with ADMENTA Italia Group (ADMENTA), a leading pharmaceutical retail and wholesale distribution company in Italy.
VIRALEZE is a broad-spectrum antiviral nasal spray, applied in the nose to provide a physical barrier between viruses and the nasal mucous membrane which traps and irreversibly inactivates viruses, including SARS-CoV-2.
ADMENTA employs 1,400 people in Italy across its wholesale and retail operations, supplying more than 2,500 pharmacies, parapharmacies, drug stores and hospitals.
Vincenzo Masci, Marketing and Procurement Director of ADMENTA-LloydsFarmacia, said: "We are delighted to have partnered with Starpharma for VIRALEZE antiviral nasal spray in Italy.

Yooma Wellness Acquires U.K. Market Leader Vitality CBD

Retrieved on:

Friday, August 20, 2021

TORONTO, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma" or the "Company") (CSE: YOOM, AQSE: YOOM), aglobal vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands, is pleased to announce it has acquired U.K.-based market leader Vitality CBD Limited (Vitality) in a transaction valued at up to 10.2 million (CAD$17.7 million) (the acquisition) via the Companys wholly-owned subsidiary, Yooma Europe Limited.

Key Points:

TORONTO, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma" or the "Company") (CSE: YOOM, AQSE: YOOM), aglobal vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands, is pleased to announce it has acquired U.K.-based market leader Vitality CBD Limited (Vitality) in a transaction valued at up to 10.2 million (CAD$17.7 million) (the acquisition) via the Companys wholly-owned subsidiary, Yooma Europe Limited.
Vitality is a market leader in the UK with presence in major retail outlets such as Boots, ASDA and Lloyds Pharmacy and we look forward to working with the team at Vitality.
Nikhil Nathwani, Co-founder and Managing Director commented on the acquisition, The whole Vitality CBD team is excited to be joining the Yooma group.
Vitality CBD is the most widely stocked brand of CBD in the UK with products distributed in national retailers such as Boots, Tesco, ASDA and Lloyds Pharmacy.